Objectives: Metabolic syndrome (MetS) promotes the establishment of diabetes mellitus (DM) and atherosclerotic cardiovascular disease (ASCVD). Prediction of individuals who are at high risk for developing MetS is essential. Vascular risk age (VRA) is a clinical substitute of cardiovascular risk. In this study we aimed to ascertain if the VRA is an indicator of MetS.
Methods: This work involved 169 subjects (96 females, 73 males, aged 40-83 year) without any previous diagnosis of ASCVD and DM. MetS was diagnosed as stated by ATP III-2005 and IDF-2009. The SCORE2/SCORE2-OP 10-year fatal CVD risk and VRA were computed for all participants.
Results: The frequency of MetS based on the ATP III-2005 criteria was 40.2% overall, 39.6% in females, and 41.1% in males, while it was 47.9% in total, 43.8% in females, and 53.4% in males based on IDF-2009 criteria. VRA was significantly higher in cases with MetS in comparison to the cases without MetS (P
Key words: Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Vascular Risk Age, Atherosclerosis
|
